Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Latest News

Market capUnder $100B
All Over $50MOver $300MOver $2BOver $10B
All Under $1BUnder $10BUnder $100BUnder $500B
SectorsAll
Filter by sector
Friday, October 23, 2026· 8856 stock ideas· 219 writers·
23,560 views· 11,170 clicks

From X

@Fierce__beast 1 click

Fierce_beast on X

$COUR I went to the website of vectorlearn (https://t.co/T8MyEtq5uW) and here is what it says: So they will collaborate closely with COUR and Udemy to create personalized learning with a 100m investment based on a valuation of 300m but who decided it was worth 300m? Also, is this kind of just like investing in R&D since they are collaboratng? This is a nice way for $COUR to not show increased expenses, and also not to show "capex" or "acquistion costs". If had factored this in as an additional expense then their earnings are even lower than i thought
@Fierce__beast 1 click

Fierce_beast on X

i am short $cour -- in the worst case it feels like they should trade at a small discount to their net cash. in the best case, the stock probably does not really do much. interesting even as a case study about large net cash position with a melting ice cube operating business, massive SBC, a big merger, a very low "p/e" the p/e is a bit of an illusion with SBC and a purchase accounting benefit they add back to show good "adj ebitda" margins. by my estimate the business is on track to make -.15/sh of real earnings. if this is true, i also estimate they need to find 45-60m of cost savings to simply break even. this is while NRR for enterprise is consistently collapsing and consumer subscriptions are generating revenues at something like 25% the rate at which they are growing. so maybe they get their deal synergies and get to +.15/sh but how long does that take and it still seems like something has been going wrong with their core business for a while now. linkedin certifications seem pretty solid. for google certifications i think you can just go direct. also the consumer business seems focused on industry certifications, which it seems the big platforms like google is providing at better terms than coursera but have historically partnered with coursera. interesting tug of war there
@RagingVentures

Raging Capital Ventures on X

Some thoughts of mine on Archegos from May 2021 (below). Was Leopold using swaps? The value of Situational’s reported Q1 13F holdings pale in comparison to some of the exposure numbers being mentioned today, even adjusting for appreciation. I would observe that once Archegos blew up at the end of March 2021, many previously impossible shorts (names like $TDOC and $TRUP come to mind) became much easier to navigate and ultimately collapsed… ****** PEELING BACK THE ARCHEGOS ONION The implosion of Archegos is a very important market development and I hope regulators peel back the onion to truly understand what occurred. Archegos owned massive swap positions in companies like ViacomCBS (VIAC), Discovery Communications (DISCA), Tencent Music (TME), and GSX Techedu (GSX), in some cases controlling 20-50% of their tradeable float. Swap ISDA agreements typically limit aggregate ownership in a single company to 4-9%. Archegos appears to have aggressively violated these limits and/or the prime brokers looked the other way, enabling the firm to corner numerous large stocks in the U.S. equity markets. Notably, Archegos owned perhaps 50% of the float of a reputed fraud, GSX. How long has Archegos’ Bill Hwang been cornering stocks like this? He is rumored to have turned $200 mm into $5 b over the past six years (and may have briefly tripled that amount to $15 b during early 2021). What other short squeezes did he orchestrate in recent years? Are other funds using similar strategies as Archegos, and were there wolf packs of funds that Archegos was communicating with on these squeezes? My hunch is that Hwang and his ilk have been cornering stocks for years, with the typical exit plan being the sale of his positions to passive indexes who are perversely designed to buy more of a stock the higher the price goes. This underscores a major issue with passive investing. Archegos’ machinations also created tremendous pain for short selling hedge funds, which provide a valuable ballast for the entire stock market. Furthermore, if you peel back the onion enough, I think you will find an Archegos (or a similar fund) connection to Tesla (TSLA), which was squeezed multiple times until it was added to the S&P 500. Is it possible that Elon Musk, who regularly attacked the shorts, and who in 2018 was making unusual pre-market trades in his own stock at prices well above the prevailing market price, was somehow connected to this action?
@AsifSuria

Asif Suria on X

A friend mentioned MarketAxess $MKTX to me years ago. I followed it for a while but never acted on it. Despite the 44% premium being paid by $ICE to acquire the company, given the five year performance of the stock, this almost feels like a take under. Reminds me of the CBIZ $CBZ acquisition by Grant Thornton from earlier this week. Even after the acquisition related pop in the stock, $CBZ is still down more than 27% over the last year.

Investor Letters

All letters

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 4 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 7 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $110M
Triple S Special Situations Investing 4 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 4 clicks
UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

UNCY $110M
Value Investors Club

Moon River Moly: Research Note

Moon River Moly’s updated Davidson PEA lifts after-tax NPV to $1.24 billion as flotation raises tungsten output 350% and cuts molybdenum…

MRIVF $16M
Atrium Research - Equity Research 1 click

Have a source we’re missing? Send your pick

Recent recaps

Latest recap

Thursday, October 22 62 stock ideas
  • This Week in Special Situations: Solstice, Albertsons, Brockhaus, GM Latticework by MOI Global
  • Mosaic, Part One: The Story Latticework by MOI Global
Read the recap

All recaps

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 247

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.

Anything we’re missing?

Send us a pick